Achillion Pharmaceuticals

ACHN

4.11

+0.01

+0.2%

After Hours:

4.11

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 4.08
Prev. Close: 4.10
Low/Hi: 4.00 - 4.16
52-Week: 3.15 - 9.19
Volumes
Equity: 793,906
90-Day Avg: 1,909,672
Option: 338
90-Day Avg: 760
Volatility
Todays Stock Vol: 42.4
20-Day (HV): 53.4
52-Week (HV): 55.8
30-Day IV: 38.9 -5.3
IV Pct Rank: 2% Subdued
Fundamental
Div. Yield: 0.0%
Earnings: 3-Nov (Est.)
P/E Ratio:
Market Cap: 560.7 M
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ACHN Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Net Income -22,543 -20,152 -4,429 -20,730
Change in Working Capital 3,062 11,193 -15,357 1,850
Depreciation Amortization Depletion and Accretion 466 475 326 386
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 2,158 2,684 2,305 3,123
Total Cash from Operating Activities -16,857 -5,800 -17,155 -15,371
Capital Expenditures -120 -214 -743 -510
Other Investing Cash Flow 9,255 -27,902 54,309 22,521
Total Cash from Investing Activities 9,135 -28,116 53,566 22,011
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 127 2 125 0
Purchase and Retirement of Debt -93 -93 363 -55
Other Financing Cash Flow 0 -175 0 0
Total Cash from Financing Activities 34 -266 488 -55
Exchange Rate Effects 0 0 0 0
Net Change in Cash -7,688 -34,182 36,899 6,585
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Net Income -61,706 -5,030 -69,008 -58,947
Change in Working Capital -16,336 323 4,712 19
Depreciation Amortization Depletion and Accretion 1,940 2,696 2,448 2,759
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 10,449 7,588 6,324 2,533
Total Cash from Operating Activities -65,653 5,577 -55,524 -53,636
Capital Expenditures -2,508 -704 -947 -408
Other Investing Cash Flow 63,177 -297,950 44,287 -64,626
Total Cash from Investing Activities 60,669 -298,654 43,340 -65,034
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 322 301,158 52,264 133,951
Purchase and Retirement of Debt 198 -20 127 -350
Other Financing Cash Flow 0 0 0 0
Total Cash from Financing Activities 520 301,138 52,391 133,601
Exchange Rate Effects 0 0 0 0
Net Change in Cash -4,464 8,061 40,207 14,931